Search research articles
Contact Us
Filters
Showing results (331-340 of 342) with videos related to
Page
of 35
Sort By:
European Urology
|
July 4, 2012
Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project)
Sabine Brookman-May, Matthias May, Shahrokh F Shariat, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
August 12, 2024
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy
Erik J van Gennep, Francesco Claps, Peter J Bostrom, et al.
European Urology Open Science
|
June 7, 2023
International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members
Irene J Beijert, Liang Cheng, Fredrik Liedberg, et al.
BJU International
|
February 7, 2023
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
Francesco Claps, Maaike W van de Kamp, Roman Mayr, et al.
European Urology
|
July 20, 2020
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?<sup>†</sup>
Bas W G van Rhijn, Laura S Mertens, Roman Mayr, et al.
Urologic Oncology
|
December 15, 2021
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
Laura S Mertens, Francesco Claps, Roman Mayr, et al.
European Urology
|
January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
Richard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
Urologic Oncology
|
November 10, 2019
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, et al.
European Urology Focus
|
May 16, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum
Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology
|
January 20, 2023
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum
Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
Page
of 35
Search research articles
Search
Showing results (331-340 of 342) with videos related to
Sort By:
Page
of 35
European Urology
|
July 4, 2012
Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project)
Sabine Brookman-May, Matthias May, Shahrokh F Shariat, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
August 12, 2024
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy
Erik J van Gennep, Francesco Claps, Peter J Bostrom, et al.
European Urology Open Science
|
June 7, 2023
International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members
Irene J Beijert, Liang Cheng, Fredrik Liedberg, et al.
BJU International
|
February 7, 2023
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
Francesco Claps, Maaike W van de Kamp, Roman Mayr, et al.
European Urology
|
July 20, 2020
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?<sup>†</sup>
Bas W G van Rhijn, Laura S Mertens, Roman Mayr, et al.
Urologic Oncology
|
December 15, 2021
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
Laura S Mertens, Francesco Claps, Roman Mayr, et al.
European Urology
|
January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
Richard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
Urologic Oncology
|
November 10, 2019
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, et al.
European Urology Focus
|
May 16, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum
Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology
|
January 20, 2023
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum
Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
Page
of 35